"
Team:UCSF/Parts1
From 2013.igem.org
(Difference between revisions)
| (15 intermediate revisions not shown) | |||
| Line 181: | Line 181: | ||
p2{ | p2{ | ||
font-size: 1.5em; | font-size: 1.5em; | ||
| + | line-height: 1.2em; | ||
| + | |||
} | } | ||
p3{ | p3{ | ||
| - | font-size: 1. | + | font-size: 1.5em; |
| + | line-height: 1.5em; | ||
} | } | ||
| Line 459: | Line 462: | ||
</div> | </div> | ||
| - | <!--Span: | + | <!--Span: Parts--> |
<script type="text/javascript"> | <script type="text/javascript"> | ||
// <![CDATA[ | // <![CDATA[ | ||
| Line 468: | Line 471: | ||
myMenu.remember = false; | myMenu.remember = false; | ||
myMenu.init(); | myMenu.init(); | ||
| - | myMenu.expandMenu(myMenu.submenus[ | + | myMenu.expandMenu(myMenu.submenus[3]); |
}; | }; | ||
// ]]> | // ]]> | ||
| Line 511: | Line 514: | ||
<h2><center> BioBrick Parts Submitted to or Characterized in the Registry </center></h2> | <h2><center> BioBrick Parts Submitted to or Characterized in the Registry </center></h2> | ||
| - | <div id="leftcontenttext" style = "width: 725px;height: | + | <div id="leftcontenttext" style = "width: 725px;height:170px;margin-left:15px" align="justify"> |
<h3>Promoters</h3> | <h3>Promoters</h3> | ||
<p2> | <p2> | ||
| - | We characterized the pLAC and pTET inducible promoters and this information is available on the Experience page for each part. | + | We characterized the pLAC and pTET inducible promoters and this information is available on the Experience page for each part.<br> |
| - | + | ||
| - | + | ||
</p2> | </p2> | ||
| + | <ul> | ||
| + | <p3> | ||
| + | <li>Part: BBa_R0011, Link: <a href=http://parts.igem.org/Part:BBa_R0011:Experience>pLAC</a><br> | ||
| + | <li>Part: BBa_R0040, Link: <a href=http://parts.igem.org/Part:BBa_R0040:Experience>pTET</a><br> | ||
| + | </p3> | ||
| + | </ul> | ||
| + | </div> | ||
| + | <div id="leftcontenttext" style = "width: 725px;height:100px;margin-left:15px" align="justify"> | ||
<h3>Guide RNAs (gRNA) for CRISPRi</h3> | <h3>Guide RNAs (gRNA) for CRISPRi</h3> | ||
<p2> | <p2> | ||
| Line 525: | Line 534: | ||
See the chart below for links to the parts registry pages for the RFP, GFP, XylE, and LacZ targeting gRNAs. | See the chart below for links to the parts registry pages for the RFP, GFP, XylE, and LacZ targeting gRNAs. | ||
</p2> | </p2> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
</div> | </div> | ||
<!------------------------------------End Context-------------------------------------> | <!------------------------------------End Context-------------------------------------> | ||
Latest revision as of 18:01, 28 October 2013
BioBrick Parts Submitted to or Characterized in the Registry
Promoters
Guide RNAs (gRNA) for CRISPRi
See the chart below for links to the parts registry pages for the RFP, GFP, XylE, and LacZ targeting gRNAs.
|
|
